NZ745950A - Methods and compositions for treating multiple sclerosis and related disorders - Google Patents
Methods and compositions for treating multiple sclerosis and related disordersInfo
- Publication number
- NZ745950A NZ745950A NZ745950A NZ74595013A NZ745950A NZ 745950 A NZ745950 A NZ 745950A NZ 745950 A NZ745950 A NZ 745950A NZ 74595013 A NZ74595013 A NZ 74595013A NZ 745950 A NZ745950 A NZ 745950A
- Authority
- NZ
- New Zealand
- Prior art keywords
- multiple sclerosis
- methods
- compositions
- treating multiple
- related disorders
- Prior art date
Links
- 201000006417 multiple sclerosis Diseases 0.000 title abstract 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 208000035475 disorder Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 239000002105 nanoparticle Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
This disclosure provides therapeutic compositions and methods for treating multiple sclerosis or a multiple sclerosis-related disorder in a subject in need thereof comprising administering an effective amount of an antigen-MHC-nanoparticle complex to the subject, wherein the antigen is a multiple sclerosis-related antigen.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261712733P | 2012-10-11 | 2012-10-11 | |
US13/830,521 US20140105980A1 (en) | 2012-10-11 | 2013-03-14 | Methods and compositions for treating multiple sclerosis and related disorders |
NZ70697013 | 2013-10-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ745950A true NZ745950A (en) | 2020-08-28 |
Family
ID=72265392
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ745950A NZ745950A (en) | 2012-10-11 | 2013-10-11 | Methods and compositions for treating multiple sclerosis and related disorders |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ745950A (en) |
-
2013
- 2013-10-11 NZ NZ745950A patent/NZ745950A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2019001977A (en) | Methods and compositions for treating multiple sclerosis and related disorders. | |
MX2020010535A (en) | Methods of treating cancer. | |
NZ707086A (en) | Anti-cd40 antibodies and methods of use | |
PH12015502075A1 (en) | Treatment of cataplexy | |
SG194701A1 (en) | Anti-cd40 antibodies and methods of use | |
WO2014145159A3 (en) | Charge-engineered antibodies or compositions of penetration-enhanced targeting proteins and methods of use | |
MX2015006234A (en) | Use of akkermansia for treating metabolic disorders. | |
MX367341B (en) | TETRAHYDRONAPHTHYRIDINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE. | |
TN2014000206A1 (en) | Antibody molecules having specificity for human ox40 | |
MX2016002645A (en) | Combination therapy for the treatment of glioblastoma. | |
MX2015002669A (en) | Methods of administering pirfenidone therapy. | |
IN2015DN00450A (en) | ||
MX360189B (en) | Combination therapy for the treatment of glioblastoma. | |
PH12016500140A1 (en) | Heterobicycloaryl rorc2 inhibitors and methods of use thereof | |
MY191932A (en) | Chitosan-derived compositions | |
MX2014001766A (en) | Neuregulin antibodies and uses thereof. | |
MX2015010296A (en) | Treatment of multiple sclerosis with laquinimod. | |
MX2016000220A (en) | Regulation of glucose metabolism using anti-cgrp antibodies. | |
EP4385563A3 (en) | Dosage forms and therapeutic uses l-4-chlorokynurenine | |
MX356317B (en) | Treatment of symptoms associated with female gastroparesis. | |
MX2016003293A (en) | Methods and compositions for treatment of chlamydial infection and related diseases and disorders. | |
EA201491522A1 (en) | METHODS OF TREATING DISORDERS OF GAIT AND / OR BALANCE IN PATIENTS WITH MULTIPLE SCLEROSIS USING AMINOPYRIDINE | |
GB201115977D0 (en) | Neurodevelopmental disorders | |
NZ745950A (en) | Methods and compositions for treating multiple sclerosis and related disorders | |
IN2014DN07989A (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 OCT 2022 BY COMPUTER PACKAGES INC Effective date: 20210917 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 OCT 2023 BY COMPUTER PACKAGES INC Effective date: 20220917 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 OCT 2024 BY COMPUTER PACKAGES INC Effective date: 20230917 |